Matthew P. Goetz, MD

Oncologist
Mayo Clinic
Rochester, MN
Authored Items
Questions About Treating Patients Using a CDK4/6 Inhibitor
Matthew P. Goetz, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video, SABCS
The Use of Chemotherapy in the Metastatic Setting
Matthew P. Goetz, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video, SABCS
The Mechanism of Action of CDK4/6 Inhibitors
Matthew P. Goetz, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video, SABCS
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
Matthew P. Goetz, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video, SABCS
Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?
Matthew P. Goetz, MD
Conference Correspondent  in SABCS 2017 - Breast Cancer, Breast Cancer, Video, SABCS
Last modified: December 5, 2017